These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population. Paz-y-Miño C, Witte T, Robles P, Llumipanta W, Díaz M, Arévalo M. Cancer Genet Cytogenet; 2009 Mar; 189(2):71-6. PubMed ID: 19215786 [Abstract] [Full Text] [Related]
30. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer. Onen IH, Ekmekci A, Eroglu M, Konac E, Yesil S, Biri H. Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534 [Abstract] [Full Text] [Related]
31. Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk. Singal R, Ferdinand L, Das PM, Reis IM, Schlesselman JJ. Int J Oncol; 2004 Nov; 25(5):1465-71. PubMed ID: 15492840 [Abstract] [Full Text] [Related]
34. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer. Wang L, Habuchi T, Tsuchiya N, Mitsumori K, Ohyama C, Sato K, Kinoshita H, Kamoto T, Nakamura A, Ogawa O, Kato T. Cancer Res; 2003 Aug 01; 63(15):4407-11. PubMed ID: 12907612 [Abstract] [Full Text] [Related]
35. The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese. Hirose K, Matsuo K, Toyama T, Iwata H, Hamajima N, Tajima K. Cancer Epidemiol Biomarkers Prev; 2004 Aug 01; 13(8):1407-11. PubMed ID: 15298966 [Abstract] [Full Text] [Related]
36. Polymorphisms in ER-alpha gene interact with estrogen receptor status in breast cancer survival. Boyapati SM, Shu XO, Ruan ZX, Cai Q, Smith JR, Wen W, Gao YT, Zheng W. Clin Cancer Res; 2005 Feb 01; 11(3):1093-8. PubMed ID: 15709176 [Abstract] [Full Text] [Related]
37. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study. Reljic A, Simundic AM, Topic E, Nikolac N, Justinic D, Stefanovic M. Clin Biochem; 2007 Sep 01; 40(13-14):981-5. PubMed ID: 17573062 [Abstract] [Full Text] [Related]
38. Full sequencing analysis of estrogen receptor-alpha gene polymorphism and its association with breast cancer risk. Han W, Kang D, Lee KM, Kim HJ, Ahn SJ, Kim SW, Chung KW, Lee ES, Noh DY. Anticancer Res; 2003 Sep 01; 23(6C):4703-7. PubMed ID: 14981916 [Abstract] [Full Text] [Related]
39. XRCC1 polymorphism and lung cancer risk. Schneider J, Classen V, Helmig S. Expert Rev Mol Diagn; 2008 Nov 01; 8(6):761-80. PubMed ID: 18999926 [Abstract] [Full Text] [Related]
40. Genetic variants in the vitamin D receptor gene and prostate cancer risk. Hayes VM, Severi G, Padilla EJ, Eggleton SA, Southey MC, Sutherland RL, Hopper JL, Giles GG. Cancer Epidemiol Biomarkers Prev; 2005 Apr 01; 14(4):997-9. PubMed ID: 15824177 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]